Polyomavirus in Renal Transplantation: A Hot Problem

[en] Polyomavirus BK has emerged as an important complication after kidney transplantation. Although, BK nephropathy develops in only1%to5%of renal transplant recipients, its prognosis when present is very poor. The most accepted risk factor is the level of immunosuppressive treatment, but the serostatus of donor and recipient and the absence of human leukocyte antigen C7 in donor and/or recipient influence the BK virus (BKV) reactivation. The gold standard in diagnosing BKV nephropathy (BKVN) continues to be biopsy with use of immunohistochemistry for large T antigens. Urinary decoy cells and blood BKV DNA polymerase chain reaction are used in the screening, but their positive predictive values are poor. However, their use as predictors of the evolution of BKVN is more valuable. The reduction of immunosuppressive therapy currently represents the first-line treatment for BKVN. Cidofovir and leflunomide can be used when BKVN continues to progress. In the event of graft loss, retransplantation is possible with a low risk of recurrence when the infection is no longer active.

Disciplines :

Immunology & infectious disease
Urology & nephrology

Author, co-author :

Bonvoisin, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Weekers, Laurent ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Xhignesse, Patricia ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Grosch, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Milicevic, Miroslav; Université de Liège - ULiège > Faculté de Médecine

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

English

Title :

Polyomavirus in Renal Transplantation: A Hot Problem

Publication date :

15 April 2008

Journal title :

Transplantation

ISSN :

0041-1337

eISSN :

1534-6080

Publisher :

Lippincott Williams & Wilkins, United States - Maryland

Volume :

Issue :

Pages :

S42-S48

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 January 2009

Statistics

Number of views

179 (8 by ULiège)

Number of downloads

567 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Gardner SD, Mackenzie EF, Smith C. Prospective study of the human polyomavirus BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
Gardner SD, Field AM, Coleman DV. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1971; 1: 1253.
Randhawa PS, Finkelstein S, Scantlebury V. Human polyoma-virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103.
Nickeleit V, Hirsch HH, Zeiler M. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
Ramos E, Darchenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
Barbanti-Brodano G, Sabbioni S, Martini F, et al. Simian virus 40 infection in humans and association with human disease: Results and hypotheses. Virology 2004; 318: 1.
Geetha D, Tong BC, Racusen L. Bladder carcinoma in a transplant recipient: Evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73: 1933.
Moret H, Ingrand D. Les polyomavirus humains. Médecine Thérapeutique 1997; 6: 473.
Dugan AS, Eash S, Atwood W. Update on BK virus entry and intracellular trafficking. Transpl Infect Dis 2006; 8: 62.
Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115.
Shah KV, Daniel R, Warszawski R. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128: 784.
Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
Boubenider S, Hiesse C, Marchand S. Post transplantation polyomavirus infection. J Nephrol 1999; 12: 24.
Colvin RB, Mauiyyedi S. Differential diagnosis between infection and rejection in renal allografts. Transplant Proc 2001; 33: 1778.
Ahuja M, Cohen EP, Dayer AM, et al. Polyomavirus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896.
Sachdeva M, Nada R, Jha V, et al. The high incidence of BK polyoma virus infection among renal transplant recipients in India. Transplantation 2004; 77: 429.
Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al.Aprospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5: 1926.
Buehrig CK, Lager DJ, Stegall MD. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665.
Drachenberg CB, Papadimitriou JC, Wali R. Improved outcome of polyoma virus allograft nephropathy with early biopsy. Transplant Proc 2004; 36: 758.
Binet I, Nickeleit V, Hirsch HH. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
Mengel M, Marwedel M, Radermacher J. Incidence of polyomavirus- nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 2003; 18: 1190.
Lopez-Rocafort L, Wang C, Miller B. A prospective evaluation of BK virus infection in renal transplant patients [Abstract]. Am J Transplant 2002; 2: S260.
Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184: 1494.
Moens V, Subramaniam N, Johansen B. A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. J Virol 1994; 68: 2393.
Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75: 1266.
Hirsch HH, Knowles W, Dickenmann M. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5: 2213.
Merlino C, Bergallo M, Gribaudo G. Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J Clin Virol 2003; 28: 265.
Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
Nickeleit V, Hirsch HH, Binet IF. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080.
Holman CJ, Van Burik JA, Hinrichs SH. Specific detection of human BK polyomavirus in urine samples of immunocompromised patients. Clin Diagn Lab Immunol 2003; 10: 66.
Ding R, Medeiros M, Dadhania D. Non invasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 in urine. Transplantation 2002; 74: 987.
Nickeleit V, Klimkait T, Binet IF. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309.
Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082.
Hirsch HH. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25.
Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the university of Maryland renal transplant program. Clinical Transplants, 2002, Chapter 12:143.
Chapman C, Flower AJ, Durrant ST. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant 1991; 7: 481.
Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117.
Kuypers DRJ, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997.
Vats AM, Saxena M, Randhawa P. Role of quantitative viral load and cidofovir therapy in the management of BK virus nephropathy [Abstract]. J Am Soc Nephrol 2001; 12: 950.
Vats A, Shapiro R, Randhawa PS. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105.
Araya CE, Lew JF, Fennel RS, et al. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplantation 2006; 10: 32.
Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704.
Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366.
Ali S, Chandraker A, Decaprio J. Inhibition of polyoma helicase activity by quinolones. J Am Soc Nephrol 2003;14: 43A.
Chandraker A, Ali S, Drachenberg CB, et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients. Am J Transplant 2004; 4(suppl 8): 587 [abstract 1564].
Leung AYH, Chan MTL, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528.
Ramos E, Vincenti F, Lu WX. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 2004; 77: 131.
Ginevri F, Pastorino N, De Santis R, et al. Retransplantation after kidney graft loss due to polyomavirus BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2004; 42: 821.
Hirsch HH, Ramos E. Retransplantation after polyomavirus-associated nephropathy: Just do it? Am J Transplant 2006; 6: 7.